Search - tctmd.com

Displaying 1 - 20 of 227

Sort: Relevancy | Date

News Conference News AHA 2025

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

Todd Neale

November 13, 2025

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

L.A. McKeown

September 14, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

News Daily News

Brachytherapy Remains an Option for DES In-Stent Restenosis

Yael L. Maxwell

January 12, 2023

Advertisement

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Top Coronary Artery Disease News of 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Brachytherapy Remains an Option for DES In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content